INS and congenital isolated hyperinsulinism: While the measurement of C-peptide may not be specific to the diagnosis of CHI, its use as an adjunct with serum insulin in the context of robust supportive clinical criteria is reasonably justified and is unlikely to over-represent the reported incidence of CHI.